Diabetes Research and Clinical Practice

Papers
(The H4-Index of Diabetes Research and Clinical Practice is 47. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 20453050
IDF diabetes Atlas: Global estimates of undiagnosed diabetes in adults for 2021297
IDF Diabetes Atlas: Estimation of Global and Regional Gestational Diabetes Mellitus Prevalence for 2021 by International Association of Diabetes in Pregnancy Study Group’s Criteria295
Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus215
Diabetes and COVID-19: A systematic review on the current evidences174
Metformin in COVID-19: A possible role beyond diabetes156
Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration141
Risk factors for mortality among COVID-19 patients132
Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients121
Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19117
Review of methods for detecting glycemic disorders108
Impact of COVID-19 lockdown on glycemic control in patients with type 1 diabetes106
Geographic distribution of metabolic syndrome and its components in the general adult population: A meta-analysis of global data from 28 million individuals100
Association of diabetes mellitus with disease severity and prognosis in COVID-19: A retrospective cohort study98
Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?95
Admission hyperglycemia and radiological findings of SARS-CoV2 in patients with and without diabetes89
Increasing prevalence of gestational diabetes mellitus when implementing the IADPSG criteria: A systematic review and meta-analysis88
Global estimates of incidence of type 1 diabetes in children and adolescents: Results from the International Diabetes Federation Atlas, 10th edition87
COVID-19 and diabetes management: What should be considered?83
The absolute and relative risk of type 2 diabetes after gestational diabetes: A systematic review and meta-analysis of 129 studies76
Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: International expert consensus recommendations69
Beyond 2020: Modelling obesity and diabetes prevalence67
GLP-1 receptor agonists and SGLT2 inhibitors for older people with type 2 diabetes: A systematic review and meta-analysis65
The triglyceride–glucose index is a more powerful surrogate marker for predicting the prevalence and incidence of type 2 diabetes mellitus than the homeostatic model assessment of insulin resistance64
Perceived risk, behavior changes and Health-related outcomes during COVID-19 pandemic: Findings among adults with and without diabetes in China63
Hyperglycemia is a strong predictor of poor prognosis in COVID-1961
High prevalence of COVID-19-associated diabetic ketoacidosis in UK secondary care60
Comorbid diabetes and the risk of disease severity or death among 8807 COVID-19 patients in China: A meta-analysis60
Knowledge, attitudes and practices towards COVID-19 among young adults with Type 1 Diabetes Mellitus amid the nationwide lockdown in India: A cross-sectional survey59
School and pre-school children with type 1 diabetes during Covid-19 quarantine: The synergic effect of parental care and technology58
Hyperglycemia and the worse prognosis of COVID-19. Why a fast blood glucose control should be mandatory57
Clinical characteristics and outcomes of COVID-19 hospitalized patients with diabetes in the United Kingdom: A retrospective single centre study57
The impact of strict COVID-19 lockdown in Spain on glycemic profiles in patients with type 1 Diabetes prone to hypoglycemia using standalone continuous glucose monitoring56
Continuous glucose monitoring: The achievement of 100 years of innovation in diabetes technology56
Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19: A narrative review56
Diabetes and Ramadan: Practical guidelines 202155
A systematic review, meta-analysis, and meta-regression of the impact of diurnal intermittent fasting during Ramadan on glucometabolic markers in healthy subjects54
Coronavirus lockdown effect on type 1 diabetes management οn children wearing insulin pump equipped with continuous glucose monitoring system54
The International Diabetes Federation’s guide for diabetes epidemiological studies54
Testing for gestational diabetes during the COVID-19 pandemic. An evaluation of proposed protocols for the United Kingdom, Canada and Australia51
High admission blood glucose independently predicts poor prognosis in COVID-19 patients: A systematic review and dose-response meta-analysis50
Liraglutide or insulin glargine treatments improves hepatic fat in obese patients with type 2 diabetes and nonalcoholic fatty liver disease in twenty-six weeks: A randomized placebo-controlled trial50
Elevated levels of circulating short-chain fatty acids and bile acids in type 2 diabetes are linked to gut barrier disruption and disordered gut microbiota48
Association is not prediction: A landscape of confused reporting in diabetes – A systematic review48
Hyperglycemia and COVID-19: What was known and what is really new?48
Mechanism and application of exosomes in the wound healing process in diabetes mellitus47
The Australian response to the COVID-19 pandemic and diabetes – Lessons learned47
0.060471057891846